Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… Vaniqa (eflornithine hydrochlorine) Cream,13.9%, Bristol-Myers Squibb NDA 21-145 7/27/00 8/3/00 8/3/00 7/8/03 Vaniqa Indications: For the reduction of unwanted facial hair in women. EFLORNITHINE HYDROCHLORIDE Cream; Topical 13.9% VANIQA WOMEN FIRST View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com